HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity

被引:42
|
作者
Keane, Niamh M. [1 ]
Pavlos, Rebecca K. [1 ]
McKinnon, Elizabeth [1 ]
Lucas, Andrew [1 ]
Rive, Craig [1 ]
Blyth, Christopher C. [2 ,3 ]
Dunn, David [1 ]
Lucas, Michaela [4 ,5 ]
Mallal, Simon [1 ,6 ]
Phillips, Elizabeth [1 ,6 ]
机构
[1] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia
[2] Univ Western Australia, Princess Margaret Hosp Children, Dept Paediat & Adolescent Med, Perth, WA 6009, Australia
[3] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia
[4] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia
[5] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia
[6] Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA
基金
美国国家卫生研究院; 比尔及梅琳达.盖茨基金会; 英国医学研究理事会;
关键词
CD4(+); CD8(+); drug reaction with eosinophilia with systemic symptoms/drug-induced hypersensitivity syndrome; drug hypersensitivity; HIV; human leukocyte antigen; nevirapine; regulatory T cells; HIV-INFECTED PATIENTS; REVERSE-TRANSCRIPTASE INHIBITOR; ADVERSE DRUG-REACTIONS; PLASMA-CONCENTRATIONS; DEPENDENT HYPERSENSITIVITY; CONTAINING REGIMENS; ASSOCIATION; POPULATION; HEPATOTOXICITY; SAFETY;
D O I
10.1097/QAD.0000000000000345
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: This study sought to examine nevirapine hypersensitivity (NVP HSR) phenotypes and their relationship with differing major histocompatibility complex (MHC) Class I and Class II alleles and the associated CD4(+) and CD8(+) T-cell NVP-specific responses and their durability over time. Methods: A retrospective cohort study compared HIV-positive patients with NVP HSR, defined by fever and hepatitis and/or rash, with those tolerant of NVP for more than 3 months. Covariates included class I (HLA-A, B, C) and class II (HLA-DR) alleles. Cellular studies examined NVP-specific CD4(+) and CD8(+) T-cell responses by interferon-gamma (IFN gamma) ELISpot assay and intracellular cytokine staining (ICS). Results: NVP HSR occurred in 19 out of 451 (4%) NVP-exposed individuals between March 1993 and December 2011. HLA associations were phenotype dependent with HLA-DRB1*01 : 01 associated with hepatitis (P = 0.02); HLA-B*35 : 01 and HLA-Cw4 associated with cutaneous NVP HSR (P = 0.001, P = 0.01), and HLA-Cw*08 was associated with NVP HSR with eosinophilia (P = 0.04) and multisystemic NVP HSR (P = 0.02). NVP-specific INF gamma responses waned significantly more than 3 months from the original reaction and were diminished or completely abrogated when either CD4(+) or CD8(+) T cells were depleted from the peripheral blood mononuclear cells culture. Conclusion: The association of specific class I and II allele pairings with specific phenotypes of NVP HSR, and cellular studies showing both CD4(+) and CD8(+) T-cell NVP-specific responses suggest that specific combinations of NVP reactive class I restricted CD8(+) and class II restricted CD4(+) T cells contribute to the immunopathogenesis of NVP HSR. (C) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
引用
收藏
页码:1891 / 1901
页数:11
相关论文
共 50 条
  • [31] CD4+ T cell help through an MHC class I-restricted TCR
    不详
    IMMUNOBIOLOGY, 2004, 209 (4-6) : 354 - 355
  • [32] Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the Enterocyte apoptosis
    Mazzarella, Giuseppe
    Stefanile, Rosita
    Camarca, Alessandra
    Giliberti, Paolo
    Cosentini, Elena
    Marano, Caterina
    Iaquinto, Gaetano
    Giardullo, Nicola
    Auricchio, Salvatore
    Sette, Alessandro
    Troncone, Riccardo
    Gianfrani, Carmen
    GASTROENTEROLOGY, 2008, 134 (04) : 1017 - 1027
  • [33] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CD8(+) T-CELLS AND CLASS II-RESTRICTED CD4(+) T-CELLS, RESPECTIVELY, MEDIATE AND REGULATE CONTACT SENSITIVITY TO DINITROFLUOROBENZENE
    BOUR, H
    PEYRON, E
    GAUCHERAND, M
    GARRIGUE, JL
    DESVIGNES, C
    KAISERLIAN, D
    REVILLARD, JP
    NICOLAS, JF
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3006 - 3010
  • [34] Role of MHC class I and CD8+ T cells in the pathogenesis of chronic rejection
    Sun, H
    Subbotin, V
    Woodward, J
    Valdivia, L
    Fung, JJ
    Rao, AS
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 319 - 319
  • [35] Reprogramming CD4 T Cells into Cytotoxic CD8 Cells by Forced Expression of CD8αβ and Class I Restricted T Cell Receptors
    Bajwa, Gagan
    Hoyer, Elisabeth
    Brenner, Daniel A.
    Paniagua, Melisa A. Martinez
    Wu, Meng-Fen
    Varadarajan, Navin
    Brenner, Malcolm K.
    Arber, Caroline
    MOLECULAR THERAPY, 2018, 26 (05) : 206 - 206
  • [36] The murine buccal mucosa is an inductive site for priming class I restricted CD8+ effector T cells in vivo
    Desvignes, C
    Estèves, F
    Etchart, N
    Bella, C
    Czerkinsky, C
    Kaiserlian, D
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1998, 113 (03): : 386 - 393
  • [37] Pivotal roles of CD8+ T cells restricted by MHC class I-like molecules in autoimmune diseases
    Das, Gobardhan
    Das, Jyoti
    Eynott, Paul
    Zhang, Yingyu
    Bothwell, Alfred L. M.
    Van Kaer, Luc
    Shi, Yufang
    JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (12): : 2603 - 2611
  • [38] THE PREDOMINANCE OF CD8+ T-CELLS AFTER INFECTION WITH MEASLES-VIRUS SUGGESTS A ROLE FOR CD8+ CLASS I MHC-RESTRICTED CYTOTOXIC LYMPHOCYTES-T (CTL) IN RECOVERY FROM MEASLES - CLONAL ANALYSES OF HUMAN CD8+ CLASS I MHC-RESTRICTED CTL
    VANBINNENDIJK, RS
    POELEN, MCM
    KUIJPERS, KC
    OSTERHAUS, ADME
    UYTDEHAAG, FGCM
    JOURNAL OF IMMUNOLOGY, 1990, 144 (06): : 2394 - 2399
  • [39] Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule
    Cohen, William M.
    Pouvelle-Moratille, Sandra
    Wang, Xiao-Fei
    Farci, Sandrine
    Munier, Gaetan
    Charron, Dominique
    Menez, Andre
    Busson, Marc
    Maillere, Bernard
    JOURNAL OF IMMUNOLOGY, 2006, 176 (09): : 5401 - 5408
  • [40] Heterogeneity of CD4+ and CD8+ T cells
    Woodland, DL
    Dutton, RW
    CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (03) : 336 - 342